SCHEMBL6983682

SCHEMBL6983682

N#Cc1ccc(CCCN2CCCc3cc(NS(=O)(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
DRD2 P14416 5/20 0.49
DRD3 P35462 5/20 0.49
HTR6 P50406 5/20 0.49
HTR2A P28223 4/20 0.49
HTR2C P28335 4/20 0.49
NR3C1 P04150 3/20 0.49
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
NLRP3 Q96P20 1/20 0.44
BRD4 O60885 1/20 0.43
AR P10275 1/20 0.43
RORC P51449 1/20 0.43
MLNR O43193 3/20 0.43
MGAT2 Q10469 1/20 0.42
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980873 0.85 NR3C1 (0.51) TP53MAPTDRD2DRD3HTR6
Hydrochloric Acid SCHEMBL6984382 0.84 NR3C1 (0.50) TP53MAPTDRD2DRD3HTR6
SCHEMBL6985317 0.82 NR3C1 (0.58) TP53MAPTNR3C1
SCHEMBL6983684 0.81 MGAT2 (0.42) HTR2ANR3C1ARMGAT2
SCHEMBL6976880 0.81 NR3C1 (0.55) TP53MAPTDRD2DRD3HTR6
SCHEMBL6981758 0.80 NR3C1 (0.56) TP53MAPTNR3C1
SCHEMBL6977969 0.80 NR3C1 (0.56) TP53MAPTDRD2DRD3HTR6
SCHEMBL6983044 0.78 NR3C1 (0.58) TP53MAPTNR3C1
SCHEMBL6984210 0.78 KMT2A (0.55) DRD2DRD3HTR6HTR2AHTR2C
SCHEMBL6976398 0.78 NR3C1 (0.51) TP53DRD2DRD3HTR6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed